Significantly decreased necrosis observed on wheat leaves inoculated with <i>ΔZtknr4</i>. by Erika Kroll (20537020)

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Combination of cAMP-enhancing and cAMP-inhibiting neuromodulation can increase or decrease the AP threshold throughout the apical dendrite in the Hay-model L5PC. by Tuomo Mäki-Marttunen (388882)

Observed response (YObs) in relation to predicted response (YPred) in the low FODMAP diet and traditional IBS diet in serum and urine samples, colored according to responders and n... by Sanna Nybacka (11547232)

Subjects:

Fig 5 - by Amanda C. Hahn (17241106)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Fig 6 - by Amanda C. Hahn (17241106)

Subjects:

Fig 7 - by Amanda C. Hahn (17241106)

Subjects:

Graphs showing the mean maximum temperature increase at the position with the highest mean temperature increase (A) and the mean temperature increase across all probes (B) for each... by Marsel Ganeyev (21453399)

Subjects:

Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. by Caroline G. Middleton (22041479)

Subjects:

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects: